Effect of early dexamethasone on outcomes of COVID-19: A quasi-experimental study using propensity score matching
Journal
Journal of microbiology, immunology, andinfection
Date Issued
2024-02-17
Author(s)
Shih, Ming-Chieh
Chen, Kai-Hsiang
Huang, Szu-Ting
Huang, Chun-Fu
Chang, Tien-Hao
Kuo, Po-Hsien
Yeh, Yi-Chen
Tsai, Wan-Chen
Pan, Mei-Yan
Li, Guei-Chi
Chen, Yi-Jie
Abstract
The RECOVERY trial demonstrated that the use of dexamethasone is associated with a 36% lower 28-day mortality in hospitalized patients with COVID-19 on invasive mechanical ventilation. Nevertheless, the optimal timing to start dexamethasone remains uncertain.
Subjects
Coronavirus; Corticosteroid; SARS-CoV-2; Timing; Viral shedding
SDGs
Publisher
Elsevier B.V.
Type
journal article